Multiple Myeloma Clinical Trials

A listing of Multiple Myeloma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 11 clinical trials
None
Daratumumab and Belatacept for Desensitization

Some kidney transplant candidates have a very low chance of getting a kidney transplant because their immune systems are "highly sensitized" to most kidney donors. Being "highly sensitized" means that they will likely have to wait a long time (more than 5 years) before an acceptable donor is found for …

  • 0 views
  • 02 Dec, 2021
  • 1 location
None
Study of Magrolimab Combinations in Participants With Relapsed/Refractory Multiple Myeloma

recommended Phase 2 dose (RP2D) of magrolimab in participants with relapsed/refractory multiple myeloma (MM) for the following combinations: magrolimab + daratumumab, magrolimab + pomalidomide + dexamethasone

bortezomib
filgrastim
granulocyte colony stimulating factor
colony stimulating factor
measurable disease
  • 0 views
  • 27 Nov, 2021
  • 1 location
None
Treatment of Selinexor in Combination With Clarithromycin Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma Patients

relapsed/refractory multiple myeloma. The hypothesis is that the addition of Selinexor to Clarithromycin, Pomalidomide and Dexamethasone will increase the overall response rate of patients with relapsed

refractory multiple myeloma
measurable disease
dexamethasone
  • 0 views
  • 28 Nov, 2021
  • 2 locations
None
Geriatric-assessment Interventions to Address Functional Deficits in Older Adults w Multiple Myeloma

Myeloma is the second most common type of blood cancer in the United States. Myeloma most commonly affects older adults. While some younger individuals do get myeloma, the average age when

cancer
  • 0 views
  • 01 Dec, 2021
  • 1 location
None
Anti-BCMA CAR-NK Cell Therapy for the Relapsed or Refractory Multiple Myeloma

The purpose of this study is to infuse BCMA CAR-NK cellsUmbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells to the patients with relapsed and refractory multiple myeloma (MM), to

  • 0 views
  • 28 Nov, 2021
  • 1 location
None
Clinical Trial for Autologus NK Cells Alone or in Combination With Isatuximab as Maintenance for Multiple Myeloma

CellProtect as compared to Isatuximab for the treatment of patients with newly diagnosed multiple myeloma who are eligible for stem cell transplantation (SCT) as maintenance after SCT.

  • 0 views
  • 02 Dec, 2021
  • 1 location
None
Isatuximab in Patients With Monoclonal Gammopathy of Renal Significance

treatment of adult patients with multiple myeloma, but it is not approved by the FDA to treat MGRS. This means that the use of isatuximab in this study is considered 'investigational'.

  • 0 views
  • 02 Dec, 2021
  • 2 locations
None
A Study of Fedratinib With IDH Inhibition in Advanced-Phase IDH-Mutated Ph-Negative Myeloproliferative Neoplasms

The purpose of this research is to gather information on the safety and effectiveness of fedratinib (a drug called a "jak inhibitor" ) in combination with ivosidenib or enasidenib (two anti-cancer drugs). While all three drugs are FDA-approved for various conditions, the US Food and Drug Administration (FDA) has not …

cancer
blast cells
myeloid leukemia
leukemia
hydroxyurea
  • 0 views
  • 29 Nov, 2021
  • 1 location
None
MGRS: Clinical-histological Features of a Multicenter Case Series

The term "Monoclonal Gammopathies of Renal Significance" (MGRS) describes a group of diseases characterized by the presence of an immunoglobulin or monoclonal immunoglobulin fraction that has the ability to cause renal damage. It is important to diagnose MGRS correctly and early as renal survival depends on the renal function present …

  • 0 views
  • 21 Nov, 2021
  • 8 locations
None
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies

This study examines the quality of life in patients with monoclonal gammopathy of unknown significance and smoldering multiple myeloma. Collecting quality of life information from patients may

  • 0 views
  • 01 Dec, 2021
  • 1 location